GLSI: Greenwich LifeSciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 170.09
Enterprise Value ($M) 164.27
Book Value ($M) 4.98
Book Value / Share 0.38
Price / Book 34.14
NCAV ($M) 4.98
NCAV / Share 0.38
Price / NCAV 34.16

Profitability (mra)
Return on Invested Capital (ROIC) -2.11
Return on Assets (ROA) -1.50
Return on Equity (ROE) -1.57

Liquidity (mrq)
Quick Ratio 6.91
Current Ratio 6.91

Balance Sheet (mrq) ($M)
Current Assets 5.82
Assets 5.83
Liabilities 0.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-20 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-03 4,516 22,477 20.09
2025-01-31 8,031 27,109 29.62
2025-01-30 9,663 25,662 37.65
2025-01-29 2,537 14,982 16.93

(click for more detail)

Similar Companies
GDTC – CytoMed Therapeutics Limited GELS – Gelteq Limited
GLMD – Galmed Pharmaceuticals Ltd. GLTO – Galecto, Inc.
GLYC – GlycoMimetics, Inc.


Financial data and stock pages provided by
Fintel.io